Stool & CSF Notes
Stool & CSF Notes
Stool & CSF Notes
Modified Fuchs-Rosenthal ruled chamber. Cells are counted in the squares marked W1, W2, W3, W4, W5.
• Multiply the cells counted by 2.
• Report the number of cells per litre (1) of c.s.f.
Example (Using 1 in 2 c.s.f. dilution and FuchsRosenthal chamber)
• If 240 cells are counted in 5 squares:
-240 2 480 Report as 480 106 cells/1*
• *Formerly, 480 106 cells/1 would have been reported as 480
cells/mm3 or 480 cells/l.
• When using an Improved Neubauer chamber: Count the cells in 4 of
the large squares. Multiply the cells counted by 5.
• Report the number of cells per litre of c.s.f. Example If 64 cells are
counted in 4 squares:
-64 5 320 Report as 320 106 cells/1.
Calculation factors when using 1 in 10 c.s.f.
dilution
Fuchs-Rosenthal chamber:
Multiply cells counted in 5 squares
by 10. Report number of cells per
litre of c.s.f.
Improved Neubauer chamber:
Multiply cells counted in 4 squares
by 25. Report number of cells per
litre of c.s.f.
Normal c.s.f.: Contains up to 5 106
cells/litre (higher in neonates). When
no WBCs are seen, report the count
as: Below 5 cells 106/1.
BIOCHEMICAL TESTING OF C.S.F.
• Biochemical c.s.f. tests which may be required include the measurement of
protein and glucose.
Note: When the Gram smear shows organisms and pus cells, little additional
information will be provided by testing for protein and glucose.
• When however no bacteria are seen in the Gram smear and the cell count is
raised, testing for protein and glucose can help to differentiate those
conditions in which lymphocytes are found in c.s.f., e.g. viral meningitis
(slightly raised protein, normal glucose) from tuberculous meningitis (high
protein, low glucose).
• Measurement of c.s.f. glucose Glucose must be measured within 20 minutes
of the c.s.f. being withdrawn otherwise a falsely low result will be obtained
due to glycolysis.
• Use the supernatant fluid from centrifuged c.s.f. or uncentrifuged c.s.f. if
the sample appears clear.
• Glucose can be measured in c.s.f. using a colorimetric technique or a
simpler semiquantitative technique using Benedict’s reagent.
Normal c.s.f. glucose: This is about half to two thirds that
found in blood i.e. 2.5–4.0 mmol/1 (45–72 mg%).
Raised c.s.f. glucose: Occurs when the blood glucose level is
raised (hyperglycaemia) and sometimes with encephalitis.
Low c.s.f. glucose: The c.s.f. glucose concentration is reduced
in most forms of meningitis, except viral meningitis. In
pyogenic bacterial meningitis it is markedly reduced and may
even be undetectable.
Measurement of c.s.f. total protein and
globulin test
• Use the supernatant fluid from centrifuged c.s.f. or uncentrifuged c.s.f. when the sample
appears clear.
• Total protein can be measured in c.s.f. using a colorimetric technique or a visual comparative
technique.
• Pandy’s test is a screening test which detects rises in c.s.f. globulin. It is of value when it is not
possible to measure c.s.f. total protein.
Normal c.s.f. protein: Total c.s.f. protein is normally 0.15–0.40 g/l (15–40 mg%). The range for
ventricular fluid is slightly lower. Values up to 1.0 g/l (100 mg%) are normal for newborn infants.
Only traces of globulin are found in normal c.s.f., insufficient to give a positive Pandy’s test.
Increased c.s.f. total protein with positive Pandy’s test: Occurs in all forms of meningitis, in
amoebic and trypanosomiasis meningoencephalitis, cerebral malaria, brain tumours, cerebral
injury, spinal cord compression, poliomyelitis, the Guillain-Barré syndrome (often the only
abnormality), and polyneuritis.
Increases in c.s.f. protein also occur in diseases which cause changes in plasma proteins such as
myelomatosis. When the total protein exceeds 2.0 g/l (200 mg%), the fibrinogen level is usually
increased sufficiently to cause the c.s.f. to clot. This may occur in severe pyogenic meningitis,
spinal block, or following haemorrhage.
Note: In diseases of the nervous system such as multiple sclerosis, neurosyphilis, and some connective tissue disorders it is possible to find a positive Pandy’s
test for gobulin with only a slight rise or even normal total protein.
Ziehl-Neelsen smear when tuberculous
meningitis is suspected
• Examine a Ziehl-Neelsen stained c.s.f. smear for acid fast bacilli (AFB)
when tuberculous meningitis is clinically suspected or the c.s.f. contains
lymphocytes and the glucose concentration is low and the protein raised.
AFB, however, are difficult to detect in c.s.f. The following technique
increases the chances of finding the bacteria:
1. Centrifuge the c.s.f. at high speed for 20–30 minutes. Remove the
supernatant fluid and mix the sediment. Transfer several drops of the
sediment to a slide, allowing each drop to dry before adding the next.
2. Fix the dry preparation with methanol and stain by the Ziehl-Neelsen
technique .
3. Examine the smear first with 40 objective to see the distribution of
material and then with the 100 objective to detect the AFB. Examine the
entire preparation.
India ink preparation when cryptococcal
meningitis is suspected
• When cryptococcal meningitis is clinically suspected, e.g. patient with HIV disease, or
when yeast cells are detected when performing a cell count or examining a Gram smear,
examine an India ink preparation or a wet preparation by dark-field microscopy for
encapsulated yeasts.
1. Centrifuge the c.s.f. for 5–10 minutes. Remove the supernatant fluid and mix the
sediment.
2. Transfer a drop of the sediment to a slide, cover with a cover glass and examine by
dark-field microscopy or add a drop of India ink (Pelikan black drawing ink is
suitable*), mix and cover with a cover glass. *When ink is not available, use nigrosin
200 g/l (20% w/v) solution.
Note: Do not make the preparation too thick otherwise the cells and capsules will not be
seen. 3 Examine the preparation using the 40 objective. Look for oval or round cells, some
showing budding, irregular in size, measuring 2–10 µm in diameter and surrounded by a
large unstained capsule. Very occasionally capsules are absent.
Important: When encapsulated yeasts are detected in c.s.f., a presumptive diagnosis of
cryptococcal meningitis can be made.
Wet preparation and Giemsa smear
when trypanosomiasis meningoencephalitis is suspected Fresh c.s.f. is
required to detect trypanosomes. About 15 minutes after the fluid is
withdrawn, the trypanosomes begin to lose their motility and are rapidly
lyzed. The trypanosomes are usually few and therefore a careful search
of a wet preparation is required to detect the motile flagellates.
1. Centrifuge the c.s.f. at about 1000 g for 10 minutes. Remove the
supernatant fluid and mix the sediment.
2. Transfer a drop of sediment to a slide and cover with a cover glass.
Examine for motile trypanosomes using the 40 objective with the
condenser iris closed sufficiently to give good contrast. Alternatively
examine the preparation by darkfield microscopy
Double centrifugation technique
• When a microhaematocrit centrifuge is available, a more sensitive
method of detecting trypanosomes in c.s.f. is to use a double
centrifugation technique.
• This involves transferring the sediment from centrifuged c.s.f. to a
capillary tube, and centrifuging it for a further 1 minute in a
microhaematocrit centrifuge.
• The capillary tube is mounted on a slide and the preparation examined
for motile trypanosomes
Note: African trypanosomiasis and the investigations which are used to
diagnose late stage disease including testing for IgM in c.s.f.
Giemsa smear to detect morula cells
• When no trypanosomes are seen in the wet preparation, remove the
cover glass and allow the preparation to air-dry. Fix the smear with
methanol and stain it using Giemsa technique or Field’s rapid stain as
used for thin films.
• Examine the preparation for morula cells (IgM producing cells) using
the 40 objective. The cells are easily recognized.
• They are larger than lymphocytes with a dark mauve staining nucleus
and characteristic vacuoles in their cytoplasm .
• Finding morula cells in the c.s.f. of a person with African
trypanosomiasis, indicates central nervous system involvement.
Wet preparation to detect amoebae
• Examine a wet preparation for motile amoebae when primary amoebic
meningoencephalitis is clinically suspected (rare condition caused by N. fowleri)
or the c.s.f. contains pus cells with raised protein and low glucose, but no bacteria
are seen in the Gram smear. Red cells may also be present.
1. Transfer a drop of uncentrifuged purulent c.s.f. or a drop of sediment from a
centrifuged specimen to a slide and cover with a cover glass.
2. Examine the preparation using the 10 and 40 objectives, with the condenser
closed sufficiently to give good contrast. Look for small, clear, motile,
elongated forms among the pus cells. Use the 40 objective to identify the
amoebae (even if not first seen using the 10 objective, always examine the
preparation with the 40 objective).
3. The amoebae often contain vacuoles but not red cells. Further information on
amoebic meningoencephalitis.
Important: When amoebae are seen in the c.s.f., immediately notify the medical
officer attending the patient. Amoebic meningocephalitis is a rapidly fatal condition.
Examining and reporting the cultures
Chocolate agar and blood agar cultures
• Look especially for colonies that could be: Neisseria meningitidis (growing on chocolate agar and blood agar,
oxidase positive.
• Streptococcus pneumoniae (sensitive to optochin)
• Haemophilus influenzae (growing only on chocolate agar)
• Cryptococcus neoformans (Gram stain the colonies)
MacConkey agar culture
• Look especially for colonies that could be: Escherichia coli or other coliform, Streptococcus agalactiae,
Listeria monocytogenes.
• Other bacteria that cause neonatal meningitis .
Streptococcus suis identification:
S. suis is a non-haemolytic Gram positive coccus, belonging to Lancefield Group D.
It is CAMP negative, hydrolyzes aesculin and is able to grow on bile agar.
Antimicrobial susceptibility testing Test isolates of S. pneumoniae for susceptibility to chloramphenicol and
penicillin (use 1µg oxacillin disc).
Test H. influenzae for beta-lactamase production and susceptibility to chloramphenicol (using chocolate agar).
Perform susceptibility testing on Gram negative rods as indicated.
END